Bright Minds Biosciences Inc.

• Bright Minds Biosciences Inc. (CN:DRUG) Gains Momentum as Investor Optimism Supports Upside Potential
  kalkine.ca · 21 Oct 2026
• Bright Minds Biosciences Inc. (CN:DRUG) Climbs 7.80% on 15 October 2026 as Investor Optimism Builds
  kalkine.ca · 16 Oct 2026
• Bright Minds Biosciences’ Conference Schedule Keeps Drug-Resistant Epilepsy Research in Focus (CN:DRUG)
  kalkine.ca · 15 Oct 2026
• Bright Minds Biosciences Inc. (DRUG) Earnings Date, Reports and Estimates
  Traders Union · 15 Oct 2026
• Bright Minds Biosciences (NASDAQ:DRUG) Now Covered by Analysts at Wolfe Research
  MarketBeat · 15 Oct 2026
• Bright Minds Biosciences (NASDAQ:DRUG) Stock Price Up 6.6% - Here's Why
  MarketBeat · 15 Oct 2026
• Bright Minds Biosciences (NASDAQ:DRUG) Shares Climb 6.4% - What's Next?
  MarketBeat · 07 Oct 2026
• Bright Minds Biosciences Inc. (CN:DRUG) Gains 2.75% as Green Momentum Strengthens and Investor Sentiment Improves
  kalkine.ca · 06 Oct 2026
• Bright Minds Biosciences Stock Rises 2.75% as BMB-101 Moves Toward Registrational Trials (CN:DRUG)
  kalkine.ca · 06 Oct 2026
• Bright Minds Biosciences (DRUG) Edges Higher: Shares Climb 3.01% to $50.69 - CTA Positioning
  https://www.siam.in/ · 02 Oct 2026
• Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference
  GlobeNewswire · 30 Sep 2026
• Lifesci Capital Upgrades Bright Minds Biosciences (NASDAQ:DRUG) to "Strong-Buy"
  MarketBeat · 30 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →